Screener
Alamar Biosciences ALMR CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Alamar Biosciences in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Alamar Biosciences’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213424
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net cash used in operating activities | (20,347) | (13,068) |
| Cash flows from investing activities: | ||
| Maturities of short-term investments | — | 18,000 |
| Purchases of property and equipment | (600) | (554) |
| Capitalized software development costs | (178) | (428) |
| Net cash (used in) provided by investing activities | (778) | 17,018 |
| Cash flows from financing activities: | ||
| Proceeds from issuance of convertible notes | 56,500 | — |
Item 1. Financial Statements
FAQ
- What is Alamar Biosciences's capex?
- Alamar Biosciences (ALMR) reported capex of $600K in Q1 2026.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Alamar Biosciences's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude